117 related articles for article (PubMed ID: 37929341)
1. Paricalcitol improved cardiac hypertrophy and fibrosis through upregulation of fibroblast growth factor-23 and downregulation of transforming growth factor-beta in a rat model of isoproterenol-induced cardiomyopathy.
Wu CJ; Li YH; Chen HH
Chin J Physiol; 2023; 66(5):306-312. PubMed ID: 37929341
[TBL] [Abstract][Full Text] [Related]
2. Paricalcitol Attenuates Cardiac Fibrosis and Expression of Endothelial Cell Transition Markers in Isoproterenol-Induced Cardiomyopathic Rats.
Lai CC; Liu CP; Cheng PW; Lu PJ; Hsiao M; Lu WH; Sun GC; Liou JC; Tseng CJ
Crit Care Med; 2016 Sep; 44(9):e866-74. PubMed ID: 27065465
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of Transient Receptor Potential Canonical Type 3 Channel via AT1R/TGF-
He R; Zhang J; Luo D; Yu Y; Chen T; Yang Y; Yu F; Li M
Oxid Med Cell Longev; 2019; 2019():4025496. PubMed ID: 31871548
[TBL] [Abstract][Full Text] [Related]
4. Sodium houttuyfonate against cardiac fibrosis attenuates isoproterenol-induced heart failure by binding to MMP2 and p38.
Tan R; You Q; Cui J; Wang M; Song N; An K; Lin L; Adu-Amankwaah J; Yuan J; Sun H
Phytomedicine; 2023 Jan; 109():154590. PubMed ID: 36610170
[TBL] [Abstract][Full Text] [Related]
5. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
[TBL] [Abstract][Full Text] [Related]
6. Fibrosis growth factor 23 is a promoting factor for cardiac fibrosis in the presence of transforming growth factor-β1.
Kuga K; Kusakari Y; Uesugi K; Semba K; Urashima T; Akaike T; Minamisawa S
PLoS One; 2020; 15(4):e0231905. PubMed ID: 32315372
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective Effects of Paricalcitol Alone and in Combination With FGF23 Receptor Inhibition in Chronic Renal Failure: Experimental and Clinical Studies.
Czaya B; Seeherunvong W; Singh S; Yanucil C; Ruiz P; Quiroz Y; Grabner A; Katsoufis C; Swaminathan S; Abitbol C; Rodriguez-Iturbe B; Faul C; Freundlich M
Am J Hypertens; 2019 Jan; 32(1):34-44. PubMed ID: 30329020
[TBL] [Abstract][Full Text] [Related]
8. Cardiac effect of vitamin D receptor modulators in uremic rats.
Mizobuchi M; Ogata H; Yamazaki-Nakazawa A; Hosaka N; Kondo F; Koiwa F; Kinugasa E; Shibata T
J Steroid Biochem Mol Biol; 2016 Oct; 163():20-7. PubMed ID: 27072785
[TBL] [Abstract][Full Text] [Related]
9. Protective role of berberine in isoprenaline-induced cardiac fibrosis in rats.
Che Y; Shen DF; Wang ZP; Jin YG; Wu QQ; Wang SS; Yuan Y
BMC Cardiovasc Disord; 2019 Oct; 19(1):219. PubMed ID: 31615408
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D receptor activation, left ventricular hypertrophy and myocardial fibrosis.
Panizo S; Barrio-Vázquez S; Naves-Díaz M; Carrillo-López N; Rodríguez I; Fernández-Vázquez A; Valdivielso JM; Thadhani R; Cannata-Andía JB
Nephrol Dial Transplant; 2013 Nov; 28(11):2735-44. PubMed ID: 24013683
[TBL] [Abstract][Full Text] [Related]
11. Role of miR-24, Furin, and Transforming Growth Factor-β1 Signal Pathway in Fibrosis After Cardiac Infarction.
Chen Z; Lu S; Xu M; Liu P; Ren R; Ma W
Med Sci Monit; 2017 Jan; 23():65-70. PubMed ID: 28055991
[TBL] [Abstract][Full Text] [Related]
12. Shensong Yangxin Capsule prevents diabetic myocardial fibrosis by inhibiting TGF-β1/Smad signaling.
Shen N; Li X; Zhou T; Bilal MU; Du N; Hu Y; Qin W; Xie Y; Wang H; Wu J; Ju J; Fang Z; Wang L; Zhang Y
J Ethnopharmacol; 2014 Nov; 157():161-70. PubMed ID: 25267579
[TBL] [Abstract][Full Text] [Related]
13. Understanding aconite's anti-fibrotic effects in cardiac fibrosis.
Xing Z; Yang C; Feng Y; He J; Peng C; Li D
Phytomedicine; 2024 Jan; 122():155112. PubMed ID: 37924690
[TBL] [Abstract][Full Text] [Related]
14. Higenamine attenuates cardiac fibroblast abstract and fibrosis via inhibition of TGF-β1/Smad signaling.
Zhu JX; Ling W; Xue C; Zhou Z; Zhang YS; Yan C; Wu MP
Eur J Pharmacol; 2021 Jun; 900():174013. PubMed ID: 33766620
[TBL] [Abstract][Full Text] [Related]
15. Fibronectin and transforming growth factor beta contribute to erythropoietin resistance and maladaptive cardiac hypertrophy.
Morais C; Small DM; Vesey DA; Martin J; Johnson DW; Gobe GC
Biochem Biophys Res Commun; 2014 Feb; 444(3):332-7. PubMed ID: 24462876
[TBL] [Abstract][Full Text] [Related]
16. The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload.
Meems LM; Cannon MV; Mahmud H; Voors AA; van Gilst WH; Silljé HH; Ruifrok WP; de Boer RA
J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):282-9. PubMed ID: 22800987
[TBL] [Abstract][Full Text] [Related]
17. MiR-30e Attenuates Isoproterenol-induced Cardiac Fibrosis Through Suppressing Snai1/TGF-β Signaling.
Zhang W; Chang H; Zhang H; Zhang L
J Cardiovasc Pharmacol; 2017 Dec; 70(6):362-368. PubMed ID: 28777253
[TBL] [Abstract][Full Text] [Related]
18. Curcumin reduces cardiac fibrosis by inhibiting myofibroblast differentiation and decreasing transforming growth factor β1 and matrix metalloproteinase 9 / tissue inhibitor of metalloproteinase 1.
Ma J; Ma SY; Ding CH
Chin J Integr Med; 2017 May; 23(5):362-369. PubMed ID: 26956464
[TBL] [Abstract][Full Text] [Related]
19. Salmonella pathogenicity island 1 knockdown confers protection against myocardial fibrosis and inflammation in uremic cardiomyopathy via down-regulation of S100 Calcium Binding Protein A8/A9 transcription.
Cai X; Hong L; Liu Y; Huang X; Lai H; Shao L
Ren Fail; 2022 Dec; 44(1):1819-1832. PubMed ID: 36299239
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor regulates TGF-β signalling in systemic sclerosis.
Zerr P; Vollath S; Palumbo-Zerr K; Tomcik M; Huang J; Distler A; Beyer C; Dees C; Gela K; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2015 Mar; 74(3):e20. PubMed ID: 24448349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
